Yoon‐Kyo An

583 total citations
24 papers, 329 citations indexed

About

Yoon‐Kyo An is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Yoon‐Kyo An has authored 24 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 16 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Yoon‐Kyo An's work include Inflammatory Bowel Disease (18 papers), Microscopic Colitis (16 papers) and Viral gastroenteritis research and epidemiology (2 papers). Yoon‐Kyo An is often cited by papers focused on Inflammatory Bowel Disease (18 papers), Microscopic Colitis (16 papers) and Viral gastroenteritis research and epidemiology (2 papers). Yoon‐Kyo An collaborates with scholars based in Australia, United Kingdom and United States. Yoon‐Kyo An's co-authors include Jakob Begun, Robert V. Bryant, Peter De Cruz, Graham Radford‐Smith, Matthew C. Choy, Daniel R. van Langenberg, Emily K. Wright, Alexander C. Ford, Sally Bell and Samuel P. Costello and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Yoon‐Kyo An

22 papers receiving 324 citations

Peers

Countries citing papers authored by Yoon‐Kyo An

Since Specialization

Citations

This map shows the geographic impact of Yoon‐Kyo An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoon‐Kyo An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoon‐Kyo An more than expected).

Fields of papers citing papers by Yoon‐Kyo An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoon‐Kyo An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoon‐Kyo An. The network helps show where Yoon‐Kyo An may publish in the future.

Co-authorship network of co-authors of Yoon‐Kyo An

This figure shows the co-authorship network connecting the top 25 collaborators of Yoon‐Kyo An. A scholar is included among the top collaborators of Yoon‐Kyo An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoon‐Kyo An. Yoon‐Kyo An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s disease 2025 ·Intestinal Research ·(unknown), (unknown), (unknown), (unknown), Yoon‐Kyo An, Jakob Begun	1
2	Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading 2025 ·Alimentary Pharmacology & Therapeutics ·(unknown), Thomas M Goodsall, Claire E. Parker, Alice S. Day, Yoon‐Kyo An, (unknown), Chamara Basnayake, Jakob Begun, Ray Boyapati, Rebecca Burgell, Michael T. Dolinger, Giovanni Maconi, Kerri L. Novak, Shintaro Sagami, Rebecca L. Smith, Ashish Srinivasan, Stuart A. Taylor, Vipul Jairath, Christopher Ma, Robert V. Bryant	2
3	DOP106 Geographic disparities in Healthcare Utilisation in people with inflammatory bowel disease, Crohn’s Colitis Cure Data Insights Program 2025 ·Journal of Crohn s and Colitis ·Wen‐Yu Su, Wayne H. Wilson, Weng Ng, Huan Su, Alistair Forbes, G Walker, Alex Kim, Edward Giles, Ian C. Lawrance, Shoma Dutt, (unknown), Yoon‐Kyo An, Kate D. Lynch, Susan J. Connor, Jane M. Andrews	0
4	Point‐of‐Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations 2025 ·Journal of Gastroenterology and Hepatology ·(unknown), (unknown), (unknown), Emily Barr, (unknown), Hai Pham, Yoon‐Kyo An, Jakob Begun	1
5	P854 Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), Robert G. Bryant, (unknown), Susan J. Connor, (unknown), Anthony Croft, Kate D. Lynch, Miles Sparrow, Peter De Cruz, Yoon‐Kyo An, Gerald Holtmann, Jakob Begun	3
6	P620 A cost-effective Inflammatory Bowel Disease flare management pathway utilising rapid access intestinal ultrasound and nurse-led triage to achieve hospital avoidance with increased patient satisfaction 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), H Harris, (unknown), (unknown), Jakob Begun, Yoon‐Kyo An	2
7	Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero 2024 ·Clinical Gastroenterology and Hepatology ·(unknown), Emma Flanagan, Emily K. Wright, Peter G. Gibson, (unknown), Ourania Rosella, Jakob Begun, Yoon‐Kyo An, Ian C. Lawrance, Michael A. Kamm, Miles Sparrow, Rimma Goldberg, Lani Prideaux, Sara Vogrin, Katerina Kiburg, Alyson L Ross, (unknown), Sally Bell	7
8	Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial 2024 ·Clinical Gastroenterology and Hepatology ·(unknown), Sudarshan Paramsothy, Viraj C. Kariyawasam, Ramesh Paramsothy, (unknown), Craig Haifer, Yoon‐Kyo An, Jakob Begun, Susan J. Connor, Crispin Corte, Mark G. Ward, Peter De Cruz, (unknown), Diane Redmond, Webber Chan, Fadi H. Mourad, (unknown), Rupert W. Leong	8
9	Comprehensive systematic review and pooled analysis of real‐world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatment 2023 ·JGH Open ·(unknown), Andrew Lee, Teresa Neeman, Yoon‐Kyo An, Jakob Begun	1
10	P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohort 2023 ·Journal of Crohn s and Colitis ·Yoon‐Kyo An, (unknown), (unknown), (unknown), (unknown), (unknown), Lena Thin, (unknown), (unknown), Emily K. Wright, Roy E. Smith, Antony B. Friedman, Jakob Begun, (unknown)	1
11	Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis 2023 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), Yoon‐Kyo An, Jakob Begun	35
12	Mo1722 REDUCTION OF BOWEL WALL THICKNESS AND DOPPLER SIGNALS AS EARY AS 36 HOURS PREDICTS CORTICOSTEROID RESPONSE IN A MULTI-CENTRE PROSPECTIVE COHORT OF ACUTE SEVERE ULCERATIVE COLITIS: USUC STUDY INCLUDING GENIUS COHORT 2023 ·Gastroenterology ·Yoon‐Kyo An, (unknown), (unknown), (unknown), Hai Pham, Kam‐Fai Wong, Lena Thin, Thomas M Goodsall, Robert V. Bryant, Emily K. Wright, Rebecca L. Smith, Antony B. Friedman, Jakob Begun	1
13	1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL 2023 ·Gastroenterology ·(unknown), Sudarshan Paramsothy, Viraj C. Kariyawasam, Ramesh Paramsothy, (unknown), Craig Haifer, Yoon‐Kyo An, Jakob Begun, Susan J. Connor, Crispin Corte, (unknown), Peter De Cruz, Caroline Fung, (unknown), Fadi H. Mourad, Diane Redmond, Rupert W. Leong	2
14	Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature 2023 ·Expert Opinion on Drug Safety ·(unknown), Suneel Gupta, Kavitha Subramaniam, Peter De Cruz, Gregory Moore, Yoon‐Kyo An, (unknown), (unknown), Sudarshan Paramsothy, Rupert W. Leong	2
15	Common mistakes with steroids 2021 ·Journal of Gastroenterology and Hepatology ·Yoon‐Kyo An	3
16	Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography 2020 ·Journal of Crohn s and Colitis ·Emma Flanagan, Emily K. Wright, Jakob Begun, Robert V. Bryant, Yoon‐Kyo An, Alyson L Ross, Katerina Kiburg, Sally Bell	38
17	Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease‐related knowledge 2019 ·SHILAP Revista de lepidopterología ·(unknown), Dharshan Sathananthan, Yoon‐Kyo An, (unknown), (unknown), (unknown), Samuel P. Costello, Jakob Begun, Robert V. Bryant	42
18	Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study 2019 ·Journal of Gastroenterology and Hepatology ·Craig Haifer, Ashish Srinivasan, S. Menon, Yoon‐Kyo An, (unknown), Daniel R. van Langenberg, Jakob Begun, Simon Ghaly, Lena Thin	2
19	Predicting response after infliximab salvage in acute severe ulcerative colitis 2017 ·Journal of Gastroenterology and Hepatology ·Matthew C. Choy, (unknown), Alexandra Gorelik, Yoon‐Kyo An, (unknown), Finlay Macrae, Miles Sparrow, William Connell, Gregory Moore, Graham Radford‐Smith, Daniel R. van Langenberg, Peter De Cruz	36
20	Adhesion formation after previous caesarean section-a meta-analysis and systematic review 2010 ·BJOG An International Journal of Obstetrics & Gynaecology ·Zhongjie Shi, Lin Ma, Yanfeng Yang, (unknown), A Schreiber, (unknown), (unknown), (unknown), (unknown), (unknown), Wei Lu, Yoon‐Kyo An, (unknown), Tingting Cui	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact